Long-term safety of intravenous human umbilical cord blood-derived mesenchymal stem cell therapy in rheumatoid arthritis: a 5-year follow-up study

Stem Cells Translational Medicine · Published 2026-06-18 · DOI 10.1093/stcltm/szag062

Free full text

Authors (4)

Eun Hye Park, Min Jung Kim, Kyung-Sun Kang, Kichul Shin

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Park, E., Kim, M., Kang, K., et al. (2026). Long-term safety of intravenous human umbilical cord blood-derived mesenchymal stem cell therapy in rheumatoid arthritis: a 5-year follow-up study. Stem Cells Translational Medicine. https://doi.org/10.1093/stcltm/szag062

Related articles